• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国骨骼肌松弛剂的使用情况:来自第三次全国健康与营养检查调查(NHANES III)的数据。

Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III).

作者信息

Dillon Charles, Paulose-Ram Ryne, Hirsch Rosemarie, Gu Qiuping

机构信息

Division of Health Examination Statistics, U.S. National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD 20782, USA.

出版信息

Spine (Phila Pa 1976). 2004 Apr 15;29(8):892-6. doi: 10.1097/00007632-200404150-00014.

DOI:10.1097/00007632-200404150-00014
PMID:15082991
Abstract

STUDY DESIGN

Population-based cross-sectional prevalence survey.

OBJECTIVES

To define muscle relaxant use patterns in the United States.

SUMMARY OF BACKGROUND DATA

Despite a long history of use for back pain and musculoskeletal disorders, national prevalence patterns of prescription muscle relaxant use have not been defined.

METHODS

NHANES III (1988-1994) is an in-person health examination survey of the U.S. civilian population, based on a complex, multistage probability sample design.

RESULTS

An estimated 2 million American adults reported muscle relaxant use (1-month period prevalence 1.0%; 95% confidence interval 0.8-1.3%). While virtually all (94%) used individual muscle relaxants rather than fixed combination muscle relaxant analgesics, two thirds took an additional prescription analgesic. Men and women had similar usage. Median user age was 42 years, but 16% of users were older than 60 years. Eighty-five percent of users took muscle relaxants for back pain or muscle disorders. Two thirds of muscle relaxant users had histories of recent back pain; however, only 4% of all those with a recent history of back pain reported any muscle relaxant use. Mean length of use was 2.1 years (95% confidence interval 1.6-2.6), with 44.5% taking medication longer than a year (95% confidence interval 35.7-53.3). Muscle relaxant use in the elderly, among older persons with ambulatory impairments, and in chronic obstructive pulmonary disease appeared undiminished compared with general population use.

CONCLUSIONS

Although typically recommended for short-term treatment of back pain, muscle relaxants are often used chronically and are prescribed to subpopulations potentially at risk for adverse effects.

摘要

研究设计

基于人群的横断面患病率调查。

目的

确定美国肌肉松弛剂的使用模式。

背景数据总结

尽管肌肉松弛剂用于治疗背痛和肌肉骨骼疾病已有很长历史,但全国范围内处方肌肉松弛剂的使用模式尚未明确。

方法

美国国立卫生统计中心第三次全国健康和营养检查调查(NHANES III,1988 - 1994年)是一项针对美国平民人口的面对面健康检查调查,基于复杂的多阶段概率抽样设计。

结果

估计有200万美国成年人报告使用过肌肉松弛剂(1个月患病率为1.0%;95%置信区间为0.8 - 1.3%)。几乎所有使用者(94%)使用的是单一肌肉松弛剂,而非固定复方肌肉松弛剂镇痛药,三分之二的使用者还服用了其他处方镇痛药。男性和女性的使用率相似。使用者的年龄中位数为42岁,但16%的使用者年龄超过60岁。85%的使用者使用肌肉松弛剂是为了治疗背痛或肌肉疾病。三分之二的肌肉松弛剂使用者近期有背痛病史;然而,在所有近期有背痛病史的人中,只有4%报告使用过任何肌肉松弛剂。平均使用时长为2.1年(95%置信区间为1.6 - 2.6),44.5%的使用者用药时间超过一年(95%置信区间为35.7 - 53.3)。与普通人群相比,老年人、有行动障碍的老年人以及慢性阻塞性肺疾病患者中肌肉松弛剂的使用情况似乎并未减少。

结论

尽管肌肉松弛剂通常被推荐用于背痛的短期治疗,但它们经常被长期使用,并且被开给可能有不良反应风险的亚人群。

相似文献

1
Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III).美国骨骼肌松弛剂的使用情况:来自第三次全国健康与营养检查调查(NHANES III)的数据。
Spine (Phila Pa 1976). 2004 Apr 15;29(8):892-6. doi: 10.1097/00007632-200404150-00014.
2
Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States.美国非甾体抗炎药和肌肉松弛剂用于背痛的处方情况。
Spine (Phila Pa 1976). 2004 Dec 1;29(23):E531-7. doi: 10.1097/01.brs.0000146453.76528.7c.
3
The association of tobacco use with prescription of muscle relaxants, benzodiazepines, and opioid analgesics for non-cancer pain.吸烟与非癌症疼痛患者肌肉松弛剂、苯二氮䓬类药物和阿片类镇痛药处方的关联。
Am J Addict. 2019 Feb;28(2):63-70. doi: 10.1111/ajad.12830. Epub 2019 Jan 9.
4
Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study.美国社区慢性下背痛成年人处方药使用情况:一项基于人群的横断面研究。
J Pain. 2018 Oct;19(10):1104-1112. doi: 10.1016/j.jpain.2018.04.004. Epub 2018 Apr 17.
5
The use of muscle relaxant medications in acute low back pain.
Spine (Phila Pa 1976). 2004 Jun 15;29(12):1346-51. doi: 10.1097/01.brs.0000128258.49781.74.
6
Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes.血液透析患者中肌肉松弛剂的使用:流行率、临床指征和不良结局。
Am J Kidney Dis. 2019 Apr;73(4):525-532. doi: 10.1053/j.ajkd.2018.11.008. Epub 2019 Jan 11.
7
Cyclobenzaprine utilization for musculoskeletal back pain: Analysis of 2007-2019 National Hospital Ambulatory Medical Care Survey Data.环苯扎林在肌肉骨骼腰痛中的应用:2007-2019 年全国医院门诊医疗调查数据分析。
Am J Emerg Med. 2023 Jun;68:106-111. doi: 10.1016/j.ajem.2023.03.025. Epub 2023 Mar 18.
8
Using Pain Medication Intensity to Stratify Back Pain Among Older Adults.利用疼痛药物强度对老年人群的背痛进行分层。
Pain Med. 2019 Feb 1;20(2):252-266. doi: 10.1093/pm/pny007.
9
Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.美国未确诊的阻塞性肺病:相关因素及长期死亡率
Ann Am Thorac Soc. 2015 Dec;12(12):1788-95. doi: 10.1513/AnnalsATS.201506-388OC.
10
Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018.2006 年至 2018 年美国商业保险成年人骨骼肌松弛剂的使用模式。
Pain Med. 2021 Oct 8;22(10):2153-2161. doi: 10.1093/pm/pnab088.

引用本文的文献

1
Risk of Osteoarthritis and Arthroplasty Between Baclofen and Tizanidine: A Target Trial Emulation Study.巴氯芬与替扎尼定之间骨关节炎和关节置换术的风险:一项目标试验模拟研究。
Clin Drug Investig. 2025 May 19. doi: 10.1007/s40261-025-01448-5.
2
Use of Muscle Relaxants After Surgery in Traditional Medicare Part D Enrollees.传统医疗保险计划 D 参保者术后使用肌肉松弛剂的情况。
Drugs Aging. 2024 Jul;41(7):615-622. doi: 10.1007/s40266-024-01124-x. Epub 2024 Jul 9.
3
Baclofen and the risk of fall and fracture in older adults: A real-world cohort study.
巴氯芬与老年人跌倒和骨折风险:一项真实世界的队列研究。
J Am Geriatr Soc. 2024 Jan;72(1):91-101. doi: 10.1111/jgs.18665. Epub 2023 Nov 7.
4
Baclofen and the Risk of Encephalopathy: A Real-World, Active-Comparator Cohort Study.巴氯芬与脑病风险:一项真实世界、活性对照的队列研究。
Mayo Clin Proc. 2023 May;98(5):676-688. doi: 10.1016/j.mayocp.2022.11.004. Epub 2023 Apr 5.
5
Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016.美国 2005-2016 年医师肌肉松弛剂处方评估。
JAMA Netw Open. 2020 Jun 1;3(6):e207664. doi: 10.1001/jamanetworkopen.2020.7664.
6
Risk Factors and Disability Associated with Low Back Pain in Older Adults in Low- and Middle-Income Countries. Results from the WHO Study on Global AGEing and Adult Health (SAGE).低收入和中等收入国家老年人腰痛相关的风险因素与残疾。世界卫生组织全球老龄化与成人健康研究(SAGE)的结果。
PLoS One. 2015 Jun 4;10(6):e0127880. doi: 10.1371/journal.pone.0127880. eCollection 2015.
7
Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain.关于合理使用骨骼肌松弛剂治疗急性下腰痛的考量因素。
P T. 2014 Jun;39(6):427-35.
8
Three-step treadmill test and McKenzie mechanical diagnosis and therapy to establish directional preference in a patient with lumbar spinal stenosis: a case report.三步跑步机试验和麦肯齐力学诊断与治疗以确定一名腰椎管狭窄症患者的方向偏好:病例报告
J Man Manip Ther. 2011 Feb;19(1):35-41. doi: 10.1179/2042618610Y.0000000002.
9
Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers.描述健康志愿者中卡利他滨的主观和精神运动效应。
Pharmacol Biochem Behav. 2011 Nov;100(1):138-43. doi: 10.1016/j.pbb.2011.08.011. Epub 2011 Aug 23.
10
Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers.健康志愿者中卡洛芬与羟考酮联合使用的主观和精神运动效应。
Drug Alcohol Depend. 2012 Jan 1;120(1-3):229-32. doi: 10.1016/j.drugalcdep.2011.07.006. Epub 2011 Aug 15.